Page 70 - Gaceta 545 Marzo
P. 70
REMITIDO
¢ RefeRencias
1. Multi-sponsor Surveys Inc. The 2013 Gallup target market report on the market for toric contact lenses. http://www.multisponsor.com. Informe accedido el 11 de enero de 2017
2. Nash W, Gabriel M. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluo- rometric enzymatic assay. Eye Contact Lens. 2014;40:277-282.
3. Nash W, Gabriel M, Mowrey-McKee. A comparison of various sili- cone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010; 87: E-abstract 105110.
4. In vitro and ex vivo measurement of contact angles on unworn sphe- rical lenses; significance demonstrated at the 0.05 level; Alcon data on file, 2009.
5. Eiden SB, Davis R, Bergenske P. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjec- tive measures of health, comfort, and vision. Eye Contact Lens. 2013; 39(4):290-4.
6. Lemp J, Kern J. A comparison of real time and recall comfort assess- ments. Optom Vis Sci. 2016; 93:E-abstract 165256.
7. Lemp J, Zhao X, Perry S. Retention of packing solution comfort agents. Poster presented at: 2017 American Academy of Optometry Annual Meeting; October 11-14, 2017; Chicago, IL (USA).
8. Alcon data on file, 2007.
9. Lemp J, Muya L, Driver-Scott A, Alvord L. A comparison of two
methods for assessing wetting substantivity. Poster presented at: 2016 Global Specialty Lens Symposium (GSLS); January 21-24, 2016; Las Vegas, NV (USA).
10. Marx S, Sickenberger W. Wettability of different silicone hydro- gel lens materials and blister solutions measured using non-in- vasive keratographic drying up time (NIK-DUT). Optom Vis Sci. 2016;93:E-abstract 165113.
11. Tucker R, Lemp J, Guillon M. In vitro and on eye wettability of lo- trafilcon B lenses packaged with a substantive wetting agent. Invest Ophthalmol Vis Sci. 2017;58: ARVO E-Abstract 3070.
12. Clinical Assessment of a Regimen of AIR OPTIX® plus HYDRA- GYDE® Silicone Hydrogel Lenses and HYDRAGLYDE® Con-
taining Lens Care Solutions. Clinical Assessment of a Regimen of AIR OPTIX® plus HYDRAGYDE® Silicone Hydrogel Lenses and HYDRAGLYDE® Containing Lens Care Solutions Clinical Assessment of a Regimen of AIR OPTIX® plus HYDRAGYDE® Silicone Hydrogel Lenses and HYDRAGLYDE® Containing Lens Care Solutions. Alcon data on file, 2017.
13. Wetting substantivity study. Alcon data on file, 2014.
14. Davis J, Ketelson HA, Shows A, et al. A lens care solution designed for wetting silicone hydrogel materials. Invest Ophthalmol Vis Sci.
2010;51(13): ARVO E-Abstract 3417. 15. Senchyna M, Stauffer P, Davis J,
et al. Characterization of a multi-purpose lens solution designed for silicone hydro- gel materials. Invest Ophthalmol Vis Sci. 2010;51(13): ARVO
E-Abstract 3426.
16. In a prospective, crossover, single mask clinical study of lotrafilcon
B toric contact lenses versus ocufilcon D toric, Alphafilcon A toric
and Methafilcon B toric. Alcon data on file, 2005.
17. In a prospective, single group, single mask clinical study of lotrafil-
con B toric contact lenses on a habitual wearers population of alpha- filcon A toric. Alcon data on file, 2005.
Las lentes AIR OPTIX® Plus HydraGlyde® for Astgmatism son conformes con la legislación vigente en materia de productos sanitarios. Contraindica- ciones: Alergia, inflamación, infección o irritación alrededor del ojo o en los párpados. Cualquier enfermedad sistémica que pueda exacerbarse o interferir con el uso de lentes de contacto. Uso de cualquier medicación que esté contraindicada o interfiera con el uso de lentes de contacto incluyendo medicaciones oftálmicas. Pelí- cula lagrimal inadecuada (ojo seco). Hipoestesia corneal (sensibilidad reducida de la córnea). Si los ojos enrojecen o se irritan. Posibles efectos secundarios: Sensación de cuerpo extraño. Incomodidad de la lente. Ojos rojos. Sensibilidad a la luz. Es- cozor, quemazón, picor o lagrimeo del ojo. Reducción de la visión. Arco iris o halos alrededor de las fuentes de luz. Aumento secreciones oculares. Incomodidad/dolor. Ojo seco grave o persistente. Para más información consulte las instrucciones de uso del producto. Alcon, AIR OPTIX® Plus HydraGlyde® for ASTIGMATISM, el logo de Alcon y el logo de AIR OPTIX® Plus HydraGlyde® for Astgmatism son marcas registradas de Novartis. ©2018 Novartis. Material revisado en noviembre de 2018. Código: I11811922360.
70
545Gaceta de OptometríaMARZO 2019
